Sign in
4

Changes in Ownership

Roivant Sciences Ltd. Filed Acc 0001807359-26-000018

Director sold 17,750 shares at an average $36.10 ($640,861)

  • Director acquired 17,750 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Epperly Melissa B, · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-10-01 Exercise or conversion : show line 1 in the form 10b5-1 +17,750 $4.46 $79,165 32,704 D
2026-10-01 Sale : show line 2 in the form 10b5-1 −16,850 $36.08 $607,948 15,854 D
2026-10-01 Sale : show line 3 in the form 10b5-1 −900 $36.57 $32,913 14,954 D
Open-market sales · 17,750 sh · avg $36.10 · $640,861

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-10-01 Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (Right to Buy) −17,750 151,416 D
Loading xslF345X06/wk-form4_1791237952.xml…